228 related articles for article (PubMed ID: 10380930)
41. Visualization of CD2 interaction with LFA-3 and determination of the two-dimensional dissociation constant for adhesion receptors in a contact area.
Dustin ML; Ferguson LM; Chan PY; Springer TA; Golan DE
J Cell Biol; 1996 Feb; 132(3):465-74. PubMed ID: 8636222
[TBL] [Abstract][Full Text] [Related]
42. 1H resonance assignments and secondary structure of the 13.6 kDa glycosylated adhesion domain of human CD2.
Wyss DF; Withka JM; Knoppers MH; Sterne KA; Recny MA; Wagner G
Biochemistry; 1993 Oct; 32(41):10995-1006. PubMed ID: 8105887
[TBL] [Abstract][Full Text] [Related]
43. CD2-CD58 interactions are pivotal for the activation and function of adaptive natural killer cells in human cytomegalovirus infection.
Rölle A; Halenius A; Ewen EM; Cerwenka A; Hengel H; Momburg F
Eur J Immunol; 2016 Oct; 46(10):2420-2425. PubMed ID: 27469079
[TBL] [Abstract][Full Text] [Related]
44. Quantification and modeling of tripartite CD2-, CD58FC chimera (alefacept)-, and CD16-mediated cell adhesion.
Dustin ML; Starr T; Coombs D; Majeau GR; Meier W; Hochman PS; Douglass A; Vale R; Goldstein B; Whitty A
J Biol Chem; 2007 Nov; 282(48):34748-57. PubMed ID: 17911103
[TBL] [Abstract][Full Text] [Related]
45. CD2-negative lymphoma-associated T-cells: a potential mechanism of immune-evasion in diffuse large B-cell lymphoma.
Ghosh A; Marques-Piubelli ML; Wang X; Sheu TG; Cheng J; Khan K; Lu W; Manning J; Tang G; Solis LM; Vega F
Virchows Arch; 2022 Oct; 481(4):659-663. PubMed ID: 35622145
[TBL] [Abstract][Full Text] [Related]
46. CD2-CD58 interaction and the control of T-cell interleukin-12 responsiveness. Adhesion molecules link innate and acquired immunity.
Gollob JA; Ritz J
Ann N Y Acad Sci; 1996 Oct; 795():71-81. PubMed ID: 8958918
[TBL] [Abstract][Full Text] [Related]
47. Role of interaction of CD2 molecules with lymphocyte function-associated antigen 3 in T-cell recognition of nominal antigen.
Koyasu S; Lawton T; Novick D; Recny MA; Siliciano RF; Wallner BP; Reinherz EL
Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2603-7. PubMed ID: 1690889
[TBL] [Abstract][Full Text] [Related]
48. Differential expression of cell adhesion molecules CD54/CD11a and CD58/CD2 by human melanoma cells and functional role in their interaction with cytotoxic cells.
Altomonte M; Gloghini A; Bertola G; Gasparollo A; Carbone A; Ferrone S; Maio M
Cancer Res; 1993 Jul; 53(14):3343-8. PubMed ID: 7686816
[TBL] [Abstract][Full Text] [Related]
49. Determination of pK(a) values of carboxyl groups in the N-terminal domain of rat CD2: anomalous pK(a) of a glutamate on the ligand-binding surface.
Chen HA; Pfuhl M; McAlister MS; Driscoll PC
Biochemistry; 2000 Jun; 39(23):6814-24. PubMed ID: 10841761
[TBL] [Abstract][Full Text] [Related]
50. TreeDock: a tool for protein docking based on minimizing van der Waals energies.
Fahmy A; Wagner G
J Am Chem Soc; 2002 Feb; 124(7):1241-50. PubMed ID: 11841293
[TBL] [Abstract][Full Text] [Related]
51. A dynamic CD2-rich compartment at the outer edge of the immunological synapse boosts and integrates signals.
Demetriou P; Abu-Shah E; Valvo S; McCuaig S; Mayya V; Kvalvaag A; Starkey T; Korobchevskaya K; Lee LYW; Friedrich M; Mann E; Kutuzov MA; Morotti M; Wietek N; Rada H; Yusuf S; Afrose J; Siokis A; ; Meyer-Hermann M; Ahmed AA; Depoil D; Dustin ML
Nat Immunol; 2020 Oct; 21(10):1232-1243. PubMed ID: 32929275
[TBL] [Abstract][Full Text] [Related]
52. Design, structure and biological activity of beta-turn peptides of CD2 protein for inhibition of T-cell adhesion.
Jining L; Makagiansar I; Yusuf-Makagiansar H; Chow VT; Siahaan TJ; Jois SD
Eur J Biochem; 2004 Jul; 271(14):2873-86. PubMed ID: 15233784
[TBL] [Abstract][Full Text] [Related]
53. Ligand binding by the immunoglobulin superfamily recognition molecule CD2 is glycosylation-independent.
Davis SJ; Davies EA; Barclay AN; Daenke S; Bodian DL; Jones EY; Stuart DI; Butters TD; Dwek RA; van der Merwe PA
J Biol Chem; 1995 Jan; 270(1):369-75. PubMed ID: 7529232
[TBL] [Abstract][Full Text] [Related]
54. Endothelial cell costimulation of T cell activation through CD58-CD2 interactions involves lipid raft aggregation.
Mestas J; Hughes CC
J Immunol; 2001 Oct; 167(8):4378-85. PubMed ID: 11591762
[TBL] [Abstract][Full Text] [Related]
55. Composition and sequence specific resonance assignments of the heterogeneous N-linked glycan in the 13.6 kDa adhesion domain of human CD2 as determined by NMR on the intact glycoprotein.
Wyss DF; Choi JS; Wagner G
Biochemistry; 1995 Feb; 34(5):1622-34. PubMed ID: 7849022
[TBL] [Abstract][Full Text] [Related]
56. The expression of CD2 in chronic HBV infection.
Li J; Qi B; Chen P; He L; Wang P; Ji Y; Xie M
Cell Mol Immunol; 2008 Feb; 5(1):69-73. PubMed ID: 18318997
[TBL] [Abstract][Full Text] [Related]
57. Human astrocytes are only partially competent antigen presenting cells. Possible implications for lesion development in multiple sclerosis.
Weber F; Meinl E; Aloisi F; Nevinny-Stickel C; Albert E; Wekerle H; Hohlfeld R
Brain; 1994 Feb; 117 ( Pt 1)():59-69. PubMed ID: 7511974
[TBL] [Abstract][Full Text] [Related]
58. CD2/LFA-3 or LFA-1/ICAM-1 but not CD28/B7 interactions can augment cytotoxicity by virus-specific CD8+ cytotoxic T lymphocytes.
de Waal Malefyt R; Verma S; Bejarano MT; Ranes-Goldberg M; Hill M; Spits H
Eur J Immunol; 1993 Feb; 23(2):418-24. PubMed ID: 7679643
[TBL] [Abstract][Full Text] [Related]
59. Cis interactions between CD2 and its ligands on T cells are required for T cell activation.
Li B; Lu Y; Zhong MC; Qian J; Li R; Davidson D; Tang Z; Zhu K; Argenty J; de Peredo AG; Malissen B; Roncagalli R; Veillette A
Sci Immunol; 2022 Aug; 7(74):eabn6373. PubMed ID: 35930657
[TBL] [Abstract][Full Text] [Related]
60. Nonnative intermediate state of acid-stable beta-sheet protein.
Yang JJ; Carroll AR; Yang W; Ye Y; Nguyen CN
Cell Biochem Biophys; 2000; 33(3):253-73. PubMed ID: 11325045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
